
The event, now in its third year, also revealed updates about clinical trials and healthcare for the disease.

A large electronic health records study found SARS-CoV-2 infection is associated with elevated risks of Human Papillomavirus (HPV)-related cancer.

So what words can I, a linguist and a patient with sensations perceivable only to me, use to fully capture these mast cell activation syndrome (MCAS) and postural orthostatic tachycardia syndrome (POTS) sensations to my providers? And, more generally, how can we measure our unsettling internal realities if we can’t even name them?

Two studies on potential biomarkers for myalgic encephalomyelitis (ME) were published this month. Plus, new studies about stellate ganglion blocks.

A new review paper published in Psychiatry and Clinical Neurosciences focuses on how Long COVID impacts the nervous and immune systems, and describes it as a neuroimmune condition.


Last year, immunologist Johan Van Weyenbergh published a study in The Lancet: Microbe that identified a potential blood-based biomarker for Long COVID with 94% sensitivity. Van Weyenbergh’s team discovered SARS-CoV-2 RNA transcripts in the blood cells of people with Long COVID. They also found a specific type of RNA, called ORF1ab RNA, which suggested there…
advocacy arts CDC clinical trials commentary COVID-19 precautions disability essay government policy H5N1 healthcare HHS influenza international Long COVID in children masks and respirators ME ME/CFS national COVID-19 trends NIH NIH RECOVER podcast public health Q&A research update science Trump administration updates and events vaccines wastewater surveillance